These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 9332730
21. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. Wolak ML, DeJoseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH. J Comp Neurol; 2003 Sep 22; 464(3):285-311. PubMed ID: 12900925 [Abstract] [Full Text] [Related]
25. Analysis of NPY receptor subtypes in the human frontal cortex reveals abundant Y1 mRNA and binding sites. Statnick MA, Schober DA, Mayne NG, Burnett JP, Gehlert DR. Peptides; 1997 Sep 22; 18(1):137-43. PubMed ID: 9114463 [Abstract] [Full Text] [Related]
26. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. Dumont Y, Fournier A, Quirion R. J Neurosci; 1998 Aug 01; 18(15):5565-74. PubMed ID: 9671648 [Abstract] [Full Text] [Related]
27. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA. Modin A, Malmström RE, Meister B. Neuropeptides; 1999 Aug 01; 33(4):253-9. PubMed ID: 10657500 [Abstract] [Full Text] [Related]
29. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Jacques D, Dumont Y, Fournier A, Quirion R. Neuroscience; 1997 Jul 01; 79(1):129-48. PubMed ID: 9178870 [Abstract] [Full Text] [Related]
33. The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat. Yang SN, Finnman UB, Fuxe K. Neuroreport; 1996 Nov 04; 7(15-17):2701-5. PubMed ID: 8981451 [Abstract] [Full Text] [Related]
34. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein. Palea S, Corsi M, Rimland JM, Trist DG. Br J Pharmacol; 1995 May 04; 115(1):3-10. PubMed ID: 7647980 [Abstract] [Full Text] [Related]
35. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem. Glaum SR, Miller RJ, Rhim H, Maclean D, Georgic LM, MacKenzie RG, Grundemar L. Br J Pharmacol; 1997 Feb 04; 120(3):481-7. PubMed ID: 9031753 [Abstract] [Full Text] [Related]
36. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors. Gibbs JL, Diogenes A, Hargreaves KM. Br J Pharmacol; 2007 Jan 04; 150(1):72-9. PubMed ID: 17143304 [Abstract] [Full Text] [Related]
37. Characterization of a Y1-preferring NPY/PYY receptor in HT-29 cells. Mannon PJ, Mervin SJ, Sheriff-Carter KD. Am J Physiol; 1994 Nov 04; 267(5 Pt 1):G901-7. PubMed ID: 7977753 [Abstract] [Full Text] [Related]
38. Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. Veyrat-Durebex C, Quirion R, Ferland G, Dumont Y, Gaudreau P. Neuropeptides; 2013 Jun 04; 47(3):163-9. PubMed ID: 23410741 [Abstract] [Full Text] [Related]